TABLE 2.
Function estimation scores
| Patient | Patient 1 | Patient 2 | Patient 3 | Patient 4 |
|---|---|---|---|---|
| Estimation instrument, time | ||||
| Rating time point, years after onset | 2 years | N/A | 1 year | 3 years |
| UPDRS part I | 9 | N/A | 4 | 4 |
| UPDRS part II | 33 | N/A | 24 | 15 |
| UPDRS part III | 35 | N/A | 32 | 8 |
| UPDRS part IV | N/A | N/A | N/A | N/A |
| UPDRS part V | Stage 5 | N/A | Stage 5 | Stage 1 |
| UPDRS part VI | 10% | N/A | 25% | 100% |
| ALSFRS‐R | 24 | N/A | 17 | 31 |
| HADS Depression/Anxiety | N/A | N/A | 9/9 | 13/9 |
| EQ5D/VAS | 10/N/A | N/A | 14/10 | 10/4 |
| EDSS | 8.0 | N/A | 7.5–8.0 | 5.5 |
| MMSE | N/A | N/A | 15 | 24 |
| MSIS−29 | N/A | N/A | N/A | N/A |
| SDMT | N/A | N/A | N/A | 31 |
Abbreviations: ALSFRS, ALS Functional Rating Scale; EDSS, Expanded Disability Status Scale; EQ5D, EuroQol‐5D standardized instrument for measuring generic health status; HADS, Hospital Anxiety Depression Rating Scale; MMSE, Mini‐Mental State Examination; MSIS‐29, Multiple Sclerosis Impact Scale; N/A, not available; SDMT, Symbol Digits Modalities Test; UPDRS, Unified Parkinson's Disease Rating Scale; VAS, Visual Assessment Scale.